{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:02Z","timestamp":1777983842481,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Galectin-3 (Gal-3), a member of the \u03b2-galactoside-binding protein family, is critically involved in inflammation, extracellular matrix remodelling, and cartilage degeneration in osteoarthritis (OA). This study aims to elucidate the regulation of the human galectin-3 gene (\n                    <jats:italic>LGALS3<\/jats:italic>\n                    ) promoter in SW1353 cells and its control by SOX transcription factors, known to be dysregulated during OA pathogenesis. We sought to identify key sequence elements in the\n                    <jats:italic>LGALS3<\/jats:italic>\n                    promoter responsible for its transcriptional activity and relevant transcription factors (TFs). Using luciferase reporter assays, we examined deletion variants of the 5\u2019 region (-2638\u00a0bp to +\u200952\u00a0bp) and assessed their activation potential. We also identified potential transcription factor binding sites (TFBS) through\n                    <jats:italic>in silico<\/jats:italic>\n                    analyses and confirmed SOX9 binding in the \u2212\u200993\/+49 region by chromatin immunoprecipitation using HaloCHIP\u2122. Functional assays revealed that the proximal promoter region (-97 bp to +\u200952\u00a0bp) is critical for reporter gene expression in SW1353 cells. This study demonstrates that the presence of\n                    <jats:italic>SOX9<\/jats:italic>\n                    leads to a dose-dependent decrease in\n                    <jats:italic>LGALS3<\/jats:italic>\n                    promoter activity in SW1353 cells. Consistent with this trend, SOX9 overexpression caused a modest reduction in endogenous\n                    <jats:italic>LGALS3<\/jats:italic>\n                    mRNA levels. Together, these findings highlight the importance of SOX TF interactions in regulating\n                    <jats:italic>LGALS3<\/jats:italic>\n                    expression and their potential role in chondrocytes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-50507-0","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:35:29Z","timestamp":1777980929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SOX9 represses the human galectin-3 promoter in SW1353 cells: potential implications for osteoarthritis"],"prefix":"10.1038","volume":"16","author":[{"given":"Blanca","family":"Alba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Buddiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Kaltner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Toegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"50507_CR1","doi-asserted-by":"publisher","first-page":"20807","DOI":"10.1016\/s0021-9258(17)31891-4","volume":"269","author":"SH Barondes","year":"1994","unstructured":"Barondes, S. H., Cooper, D. N., Gitt, M. A. & Leffler, H. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269, 20807\u201320810. https:\/\/doi.org\/10.1016\/s0021-9258(17)31891-4 (1994).","journal-title":"J. Biol. Chem."},{"key":"50507_CR2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.208884","author":"L Johannes","year":"2018","unstructured":"Johannes, L., Jacob, R. & Leffler, H. Galectins at a glance. J. Cell Sci. https:\/\/doi.org\/10.1242\/jcs.208884 (2018).","journal-title":"J. Cell Sci."},{"key":"50507_CR3","doi-asserted-by":"crossref","unstructured":"Stowell, S. R. et al. (eds) Galectins Vol. 2442 (2022).","DOI":"10.1007\/978-1-0716-2055-7"},{"key":"50507_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13075-017-1282-4","volume":"19","author":"SF Issa","year":"2017","unstructured":"Issa, S. F. et al. Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets. Arthritis Res. Ther. 19, 80. https:\/\/doi.org\/10.1186\/s13075-017-1282-4 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"50507_CR5","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/art.11287","volume":"48","author":"S Ohshima","year":"2003","unstructured":"Ohshima, S. et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48, 2788\u20132795. https:\/\/doi.org\/10.1002\/art.11287 (2003).","journal-title":"Arthritis Rheum."},{"key":"50507_CR6","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000164","author":"S Li","year":"2013","unstructured":"Li, S., Yu, Y., Koehn, C. D., Zhang, Z. & Su, K. Galectins in the pathogenesis of rheumatoid arthritis. J. Clin. Cell. Immunol. https:\/\/doi.org\/10.4172\/2155-9899.1000164 (2013).","journal-title":"J. Clin. Cell. Immunol."},{"key":"50507_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.semarthrit.2018.10.001","volume":"48","author":"TR Gullo","year":"2019","unstructured":"Gullo, T. R. et al. Defining multiple joint osteoarthritis, its frequency and impact in a community-based cohort. Semin. Arthritis Rheum. 48, 950\u2013957. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.001 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"50507_CR8","unstructured":"Hawker, G. A. Osteoarthritis is a serious disease. Clin. Exp. Rheumatol. (2019)."},{"key":"50507_CR9","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","volume":"23","author":"VB Kraus","year":"2015","unstructured":"Kraus, V. B., Blanco, F. J., Englund, M., Karsdal, M. A. & Lohmander, L. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthr. Cartil. 23, 1233\u20131241. https:\/\/doi.org\/10.1016\/j.joca.2015.03.036 (2015).","journal-title":"Osteoarthr. Cartil."},{"key":"50507_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep39112","volume":"6","author":"D Weinmann","year":"2016","unstructured":"Weinmann, D. et al. Galectin-3 induces a pro-degradative\/inflammatory gene signature in human chondrocytes, teaming up with Galectin-1 in osteoarthritis pathogenesis. Sci. Rep. 6, 39112. https:\/\/doi.org\/10.1038\/srep39112 (2016).","journal-title":"Sci. Rep."},{"key":"50507_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00223-020-00774-4","volume":"108","author":"KM Pichler","year":"2021","unstructured":"Pichler, K. M. et al. The dysregulated galectin network activates NF-\u03bab to induce disease markers and matrix degeneration in 3D pellet cultures of osteoarthritic chondrocytes. Calcif. Tissue Int. 108, 377\u2013390. https:\/\/doi.org\/10.1007\/s00223-020-00774-4 (2021).","journal-title":"Calcif. Tissue Int."},{"key":"50507_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00310","volume":"7","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Activation of Galectin-3 (LGALS3) transcription by injurious stimuli in the liver is commonly mediated by BRG1. Front. Cell Dev. Biol. 7, 310. https:\/\/doi.org\/10.3389\/fcell.2019.00310 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"50507_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/0008-5472.CAN-04-3578","volume":"65","author":"KH Ruebel","year":"2005","unstructured":"Ruebel, K. H. et al. Effects of DNA methylation on Galectin-3 expression in pituitary tumors. Cancer Res. 65, 1136\u20131140. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3578 (2005).","journal-title":"Cancer Res."},{"key":"50507_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.joca.2018.07.012","volume":"26","author":"KM Fisch","year":"2018","unstructured":"Fisch, K. M. et al. Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis. Osteoarthritis Cartilage 26, 1531\u20131538. https:\/\/doi.org\/10.1016\/j.joca.2018.07.012 (2018).","journal-title":"Osteoarthritis Cartilage"},{"key":"50507_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/nar\/27.6.1409","volume":"27","author":"M Wegner","year":"1999","unstructured":"Wegner, M. From head to toes: The multiple facets of Sox proteins. Nucleic Acids Res. 27, 1409\u20131420. https:\/\/doi.org\/10.1093\/nar\/27.6.1409 (1999).","journal-title":"Nucleic Acids Res."},{"key":"50507_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/art.20611","author":"T Ikeda","year":"2004","unstructured":"Ikeda, T. et al. The combination of SOX5, SOX6, and SOX9 (the SOX Trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.20611 (2004).","journal-title":"Arthritis Rheum."},{"key":"50507_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/03008207.2011.585409","volume":"52","author":"JS Lee","year":"2011","unstructured":"Lee, J. S. & Im, G. I. SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. Connect. Tissue Res. 52, 496\u2013502. https:\/\/doi.org\/10.3109\/03008207.2011.585409 (2011).","journal-title":"Connect. Tissue Res."},{"key":"50507_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1096\/fj.201800259R","volume":"33","author":"Y Takahata","year":"2019","unstructured":"Takahata, Y. et al. Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5. FASEB J. 33, 619\u2013630. https:\/\/doi.org\/10.1096\/fj.201800259R (2019).","journal-title":"FASEB J."},{"key":"50507_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.716055","volume":"11","author":"KY Peng","year":"2021","unstructured":"Peng, K. Y. et al. Stromal Galectin-1 promotes colorectal cancer cancer-initiating cell features and disease dissemination through SOX9 and \u03b2-Catenin: Development of niche-based biomarkers. Front. Oncol. 11, 716055. https:\/\/doi.org\/10.3389\/fonc.2021.716055 (2021).","journal-title":"Front. Oncol."},{"key":"50507_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s1063-4584(02)00354-0","volume":"11","author":"JF Schaefer","year":"2003","unstructured":"Schaefer, J. F., Millham, M. L., de Crombrugghe, B. & Buckbinder, L. FGF signaling antagonizes cytokine-mediated repression of Sox9 in SW1353 chondrosarcoma cells. Osteoarthritis Cartilage 11, 233\u2013241. https:\/\/doi.org\/10.1016\/s1063-4584(02)00354-0 (2003).","journal-title":"Osteoarthritis Cartilage"},{"key":"50507_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119528","volume":"278","author":"W Sang","year":"2021","unstructured":"Sang, W. et al. METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response. Life Sci. 278, 119528. https:\/\/doi.org\/10.1016\/j.lfs.2021.119528 (2021).","journal-title":"Life Sci."},{"key":"50507_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/2475-4676\/3\/3\/00143","volume":"3","author":"AM Lila","year":"2018","unstructured":"Lila, A. M., Gromova, O. A., Torshin, I. Y. & Montell, E. Molecular effects of chondroitin sulfate in osteoarthritis and herniated discs. Journal of Rheumatology and Arthritic Diseases 3, 1\u201311. https:\/\/doi.org\/10.15226\/2475-4676\/3\/3\/00143 (2018).","journal-title":"Journal of Rheumatology and Arthritic Diseases"},{"key":"50507_CR23","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1158\/0008-5472.CAN-04-1816","volume":"64","author":"T Shimura","year":"2004","unstructured":"Shimura, T. et al. Galectin-3, a novel binding partner of beta-catenin. Cancer Res. 64, 6363\u20136367. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1816 (2004).","journal-title":"Cancer Res."},{"key":"50507_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098116","author":"R Ahmed","year":"2023","unstructured":"Ahmed, R., Anam, K. & Ahmed, H. Development of Galectin-3 targeting drugs for therapeutic applications in various diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24098116 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"50507_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","volume":"44","author":"S Bouffette","year":"2023","unstructured":"Bouffette, S., Botez, I. & De Ceuninck, F. Targeting galectin-3 in inflammatory and fibrotic diseases. Trends Pharmacol. Sci. 44, 519\u2013531. https:\/\/doi.org\/10.1016\/j.tips.2023.06.001 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"50507_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05968-4","volume":"12","author":"E Cervantes-Alvarez","year":"2022","unstructured":"Cervantes-Alvarez, E. et al. Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients. Sci. Rep. 12, 1856. https:\/\/doi.org\/10.1038\/s41598-022-05968-4 (2022).","journal-title":"Sci. Rep."},{"key":"50507_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35334-x","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation. Nat. Commun. 13, 7578. https:\/\/doi.org\/10.1038\/s41467-022-35334-x (2022).","journal-title":"Nat. Commun."},{"key":"50507_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002371","author":"BD Curti","year":"2021","unstructured":"Curti, B. D. et al. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2021-002371 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"50507_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030389","author":"A Hara","year":"2020","unstructured":"Hara, A. et al. Galectin-3 as a next-generation biomarker for detecting early stage of various diseases. Biomolecules https:\/\/doi.org\/10.3390\/biom10030389 (2020).","journal-title":"Biomolecules"},{"key":"50507_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41419-021-03603-0","volume":"12","author":"W Jia","year":"2021","unstructured":"Jia, W., Wang, Z., Gao, C., Wu, J. & Wu, Q. Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis. Cell Death Dis. 12, 327. https:\/\/doi.org\/10.1038\/s41419-021-03603-0 (2021).","journal-title":"Cell Death Dis."},{"key":"50507_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11154-021-09704-7","volume":"23","author":"Y Li","year":"2022","unstructured":"Li, Y., Li, T., Zhou, Z. & Xiao, Y. Emerging roles of galectin-3 in diabetes and diabetes complications: A snapshot. Rev. Endocr. Metab. Disord. 23, 569\u2013577. https:\/\/doi.org\/10.1007\/s11154-021-09704-7 (2022).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"50507_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108939","volume":"236","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Galectin-3 regulates microglial activation and promotes inflammation through TLR4\/MyD88\/NF-kB in experimental autoimmune uveitis. Clin. Immunol. 236, 108939. https:\/\/doi.org\/10.1016\/j.clim.2022.108939 (2022).","journal-title":"Clin. Immunol."},{"key":"50507_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026246118","author":"TH Lo","year":"2021","unstructured":"Lo, T. H. et al. Galectin-3 promotes noncanonical inflammasome activation through intracellular binding to lipopolysaccharide glycans. Proc. Natl. Acad. Sci. U. S. A. https:\/\/doi.org\/10.1073\/pnas.2026246118 (2021).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"50507_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118864","volume":"277","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Pectic polysaccharide from Smilax china L. ameliorated ulcerative colitis by inhibiting the galectin-3\/NLRP3 inflammasome pathway. Carbohydr. Polym. 277, 118864. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118864 (2022).","journal-title":"Carbohydr. Polym."},{"key":"50507_CR35","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1053\/j.gastro.2005.09.002","volume":"129","author":"S Song","year":"2005","unstructured":"Song, S. et al. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology 129, 1581\u20131591. https:\/\/doi.org\/10.1053\/j.gastro.2005.09.002 (2005).","journal-title":"Gastroenterology"},{"key":"50507_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1892265","volume":"10","author":"ER Sturgill","year":"2021","unstructured":"Sturgill, E. R. et al. Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity. Oncoimmunology 10, 1892265. https:\/\/doi.org\/10.1080\/2162402X.2021.1892265 (2021).","journal-title":"Oncoimmunology"},{"key":"50507_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12855","volume":"74","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Melatonin inhibits atherosclerosis progression via galectin-3 downregulation to enhance autophagy and inhibit inflammation. J. Pineal Res. 74, e12855. https:\/\/doi.org\/10.1111\/jpi.12855 (2023).","journal-title":"J. Pineal Res."},{"key":"50507_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713111","author":"B Zaborska","year":"2023","unstructured":"Zaborska, B. et al. The role of Galectin-3 in heart failure-the diagnostic, prognostic and therapeutic potential-where do we stand?. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241713111 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"50507_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00418-014-1234-x","volume":"142","author":"S Toegel","year":"2014","unstructured":"Toegel, S. et al. Human osteoarthritic knee cartilage: Fingerprinting of adhesion\/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration. Histochem. Cell Biol. 142, 373\u2013388. https:\/\/doi.org\/10.1007\/s00418-014-1234-x (2014).","journal-title":"Histochem. Cell Biol."},{"key":"50507_CR40","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.1093\/nar\/gkv688","volume":"43","author":"CF Liu","year":"2015","unstructured":"Liu, C. F. & Lefebvre, V. The transcription factors SOX9 and SOX5\/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis. Nucleic Acids Res. 43, 8183\u20138203. https:\/\/doi.org\/10.1093\/nar\/gkv688 (2015).","journal-title":"Nucleic Acids Res."},{"key":"50507_CR41","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1101\/gad.1171104","volume":"18","author":"H Akiyama","year":"2004","unstructured":"Akiyama, H. et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18, 1072\u20131087. https:\/\/doi.org\/10.1101\/gad.1171104 (2004).","journal-title":"Genes Dev."},{"key":"50507_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019152118","author":"A Haseeb","year":"2021","unstructured":"Haseeb, A. et al. SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation\/osteoblastic redifferentiation. Proc. Natl. Acad. Sci. U. S. A. https:\/\/doi.org\/10.1073\/pnas.2019152118 (2021).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"50507_CR43","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.joca.2015.06.014","volume":"23","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis. Osteoarthritis Cartilage 23, 2259\u20132268. https:\/\/doi.org\/10.1016\/j.joca.2015.06.014 (2015).","journal-title":"Osteoarthritis Cartilage"},{"key":"50507_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2020.04.008","volume":"67","author":"H Song","year":"2020","unstructured":"Song, H. & Park, K. H. Regulation and function of SOX9 during cartilage development and regeneration. Semin. Cancer Biol. 67, 12\u201323. https:\/\/doi.org\/10.1016\/j.semcancer.2020.04.008 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"50507_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2021.105149","volume":"128","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. LGALS3BP\/Gal-3 promotes osteogenic differentiation of human periodontal ligament stem cells. Arch. Oral Biol. 128, 105149. https:\/\/doi.org\/10.1016\/j.archoralbio.2021.105149 (2021).","journal-title":"Arch. Oral Biol."},{"key":"50507_CR46","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1242\/dev.134502","volume":"143","author":"X He","year":"2016","unstructured":"He, X., Ohba, S., Hojo, H. & McMahon, A. P. AP-1 family members act with Sox9 to promote chondrocyte hypertrophy. Development 143, 3012\u20133023. https:\/\/doi.org\/10.1242\/dev.134502 (2016).","journal-title":"Development"},{"key":"50507_CR47","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1074\/jbc.M808048200","volume":"284","author":"L Topol","year":"2009","unstructured":"Topol, L., Chen, W., Song, H., Day, T. F. & Yang, Y. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J. Biol. Chem. 284, 3323\u20133333. https:\/\/doi.org\/10.1074\/jbc.M808048200 (2009).","journal-title":"J. Biol. Chem."},{"key":"50507_CR48","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","volume":"149","author":"VS Li","year":"2012","unstructured":"Li, V. S. et al. Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149, 1245\u20131256. https:\/\/doi.org\/10.1016\/j.cell.2012.05.002 (2012).","journal-title":"Cell"},{"key":"50507_CR49","doi-asserted-by":"publisher","unstructured":"Snelling, S. Chondrocyte isolation from human cartilage. (2019). https:\/\/doi.org\/10.17504\/protocols.io.8uphwvn","DOI":"10.17504\/protocols.io.8uphwvn"},{"key":"50507_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41587-019-0035-0","volume":"37","author":"J Tchieu","year":"2019","unstructured":"Tchieu, J. et al. NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells. Nat. Biotechnol. 37, 267\u2013275. https:\/\/doi.org\/10.1038\/s41587-019-0035-0 (2019).","journal-title":"Nat. Biotechnol."},{"key":"50507_CR51","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2144\/99264st03","volume":"26","author":"W Wang","year":"1999","unstructured":"Wang, W. & Malcolm, B. A. Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. BioTechniques 26, 680\u2013682. https:\/\/doi.org\/10.2144\/99264st03 (1999).","journal-title":"BioTechniques"},{"key":"50507_CR52","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/bioinformatics\/16.11.1046","volume":"16","author":"CB Mayor","year":"2000","unstructured":"Mayor, C. B. et al. Dubchak, I. VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 16, 1046\u20131047. https:\/\/doi.org\/10.1093\/bioinformatics\/16.11.1046 (2000).","journal-title":"Bioinformatics"},{"key":"50507_CR53","doi-asserted-by":"publisher","first-page":"W273","DOI":"10.1093\/nar\/gkh458","volume":"32","author":"KA Frazer","year":"2004","unstructured":"Frazer, K. A., Pachter, L., Poliakov, A., Rubin, E. M. & Dubchak, I. VISTA: Computational tools for comparative genomics. Nucleic Acids Res. 32, W273-279. https:\/\/doi.org\/10.1093\/nar\/gkh458 (2004).","journal-title":"Nucleic Acids Res."},{"key":"50507_CR54","doi-asserted-by":"publisher","unstructured":"Rauluseviciute, I. R. P. et al. A. JASPAR : 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res 5, D174-D182 (2024). https:\/\/doi.org\/10.1093\/nar\/gkad1059","DOI":"10.1093\/nar\/gkad1059"},{"key":"50507_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148972","volume":"933","author":"H Kaltner","year":"2025","unstructured":"Kaltner, H., Caballero, G. G. & Schmidt, S. Analysis of chicken LGALSL (galectin-related protein) gene\u2019s proximal promoter and its control by Kruppel-like factors 3 and 7. Gene 933, 148972. https:\/\/doi.org\/10.1016\/j.gene.2024.148972 (2025).","journal-title":"Gene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50507-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:52:17Z","timestamp":1777981937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50507-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50507"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50507-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of clinical specimens for this study was approved by the ethics committees of the Medical University of Vienna (EK-No.: 1922\/2017 and 1555\/2019). All methods were carried out in accordance with the approved guidelines and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"14284"}}